Date
17 October 2017

Bird flu vaccine clinical trials await approval, website says

Researchers in Shanghai have successfully developed a vaccine for H7N9 bird flu and have applied to the State Food and Drug Administration to conduct clinical trials, news website china.com.cn reported Sunday, citing the municipal public health authority. Sinovac Biotech Co. Ltd. and Hualan Biological Engineering Inc. (002007.CN) are also awaiting approval for their clinical tests on similar vaccines. Five to seven new cases of H7N9 infections are reported each day, the Chinese Center for Disease Control and Prevention was quoted as saying.

– Contact HKEJ at [email protected]

EL/AC/RA

 

EJI Weekly Newsletter

Please click here to unsubscribe